ELENA CETOLA: Open Payments
NPI 1467977843 · SOMERSET, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 30 payments from 8 companies in 2025. Trend: 2023 $233 · 2024 $815 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $159 |
| ABBVIE INC. | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $84 |
| Janssen Pharmaceuticals, Inc | 4 | $77 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, Auvelity, COBENFY, INGREZZA, Jornay PM.
Industry payments across MA — which companies pay providers there.
